Lonza | LONN - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Lonza

Lonza Group reported CHF1.24B in Gross Profit on Sales for its fiscal semester ending in December of 2022.


Gross Profit On Sales Change
Akzo Nobel AKZA:NA EUR 982M 51M
Alcon AG ALC:SW USD 1.31B 136M
Almirall SA ALM:SM EUR 335.97M 9.51M
AstraZeneca AZN:LN USD 8.83B 130M
BASF BAS:GR EUR 5.25B 905M
Bayer BAYN:GR EUR 8.66B 1.42B
Demant A/s WDH:DC DKK 7.59B 503M
Fresenius FRE:GR EUR 2.51B 273M
Fresenius Medical Care FME:GR EUR 1.15B 198.52M
Givaudan GIVN:VX CHF 1.3B 156M
GlaxoSmithKline GSK:LN GBP 5.05B 151M
GN Store Nord GN:DC DKK 2.06B 486M
Hikma Pharmaceutical HIK:LN USD 642M 19M
Johnson Matthey JMAT:LN GBP 507M 20M
Novartis NOVN:VX USD 9.38B 215M
Philips PHIA:NA EUR 1.76B 465M
Roche Holding ROG:VX 22.04B 696M
Sika AG SIKA:VX CHF 2.59B 4.6M
Smith & Nephew PLC SN/:LN 1.85B 21M
Solvay SOLB:BB EUR 1.09B 137M
UCB UCB:BB 1.76B 317M